Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients

Abstract

A key prerequisite for precision medicine is the estimation of disease progression from the current patient state. Disease correlations and temporal disease progression (trajectories) have mainly been analysed with focus on a small number of diseases or using large-scale approaches without time consideration, exceeding a few years. So far, no large-scale studies have focused on defining a comprehensive set of disease trajectories. Here we present a discovery-driven analysis of temporal disease progression patterns using data from an electronic health registry covering the whole population of Denmark. We use the entire spectrum of diseases and convert 14.9 years of registry data on 6.2 million patients into 1,171 significant trajectories. We group these into patterns centred on a small number of key diagnoses such as chronic obstructive pulmonary disease (COPD) and gout, which are central to disease progression and hence important to diagnose early to mitigate the risk of adverse outcomes. We suggest such trajectory analyses may be useful for predicting and preventing future diseases of individual patients.

References 23

1. 1.

   Camilo O. & Goldstein L. B. Seizures and epilepsy after ischemic stroke. Stroke 35, 1769–1775 (2004 ).

   Not in our library10.1161/01.str.0000130989.17100.96

2. 2.

   Finkelstein J., Cha E. & Scharf S. M. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int. J. COPD 4, 337–349 (2009 ).

   Not in our library10.2147/copd.s6400

3. 3.

   Teno J. M., Weitzen S., Fenell M. L. & Mor V. Dying trajectory in the last year of life: does cancer trajectory fit other diseases? J. Palliat. Med. 4, 457–464 (2001 ).

   Not in our library10.1089/109662101753381593

4. 4.

   Murtagh F. E. M., Murphy E. & Sheerin N. S. Illness trajectories: an important concept in the management of kidney failure. Nephrol. Dialysis Transplant 23, 3746–3748 (2008 ).

   Not in our library10.1093/ndt/gfn532

5. 5.

   Murtagh F. E. M., Sheerin N. S., Addington-Hall J. & Higginson I. J. Trajectories of illness in stage 5 chronic kidney disease: a longitudinal study of patient symptoms and concerns in the last year of life. Clin. J. Am. Soc. Nephrol. 6, 1580–1590 (2011 ).

   Not in our library10.2215/cjn.09021010

6. 6.

   Murray S. A., Kendall M., Boyd K. & Sheikh A. Illness trajectories and palliative care. BMJ 330, 1007–1011 (2005 ).

   Not in our library10.1136/bmj.330.7498.1007

7. 7.

   Petri H., Maldonato D. & Robinson N. J. Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database. BMC Musculoskelet. Disord. 11, 247 (2010 ).

   Not in our library10.1186/1471-2474-11-247

8. 8.

   Blair D. R.. A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk. Cell 155, 70–80 (2013 ).

   Not in our library10.1016/j.cell.2013.08.030

9. 9.
   A Dynamic Network Approach for the Study of Human Phenotypes · 2009

   No notice
10. 10.

    Chen L. L., Blumm N., Christakis N. A., Barabási A.-L. & Deisboeck T. S. Cancer metastasis networks and the prediction of progression patterns. Br. J. Cancer 101, 749–758 (2009 ).

    Not in our library10.1038/sj.bjc.6605214

11. 11.

    Tanushi H., Dalianis H. & Nilsson G. H. Calculating Prevalence of Comorbidity and Comorbidity Combinations with Diabetes in Hospital Care in Sweden Using a Health Care Record Database. In:Proceedings of LOUHI 2011 Third International Workshop on Health Document Text Mining and Information Analysis 59–65Bled, Slovenia (2011 ).

    Not in our library

12. 12.

    Curkendall S. M.. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann. Epidemiol. 16, 63–70 (2006 ).

    Not in our library10.1016/j.annepidem.2005.04.008

13. 13.

    Sidney S.. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 128, 2068–2075 (2005 ).

    Not in our library10.1378/chest.128.4.2068

14. 14.

    Salisbury A. C., Reid K. J. & Spertus J. A. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am. J. Cardiol. 99, 636–641 (2007 ).

    Not in our library10.1016/j.amjcard.2006.09.112

15. 15.

    Suissa S., Dell’Aniello S. & Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 67, 957–963 (2012 ).

    Not in our library10.1136/thoraxjnl-2011-201518

16. 16.

    Moss S. E., Klein R., Klein B. E. K. & Wong T. Y. Retinal vascular changes and 20-year incidence of lower extremity amputations in a cohort with diabetes. Arch. Intern. Med. 163, 2505–2510 (2003 ).

    Not in our library10.1001/archinte.163.20.2505

17. 17.

    Kohner E. M. Diabetic retinopathy. Br. Med. Bull. 45, 148–173 (1989 ).

    Not in our library10.1093/oxfordjournals.bmb.a072309

18. 18.

    Freedman D. S., Williamson D. F., Gunter E. W. & Byers T. Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I Epidemiologic Follow-up Study. Am. J. Epidemiol. 141, 637–644 (1995 ).

    Not in our library10.1093/oxfordjournals.aje.a117479

19. 19.

    Kelkar A., Kuo A. & Frishman W. H. Allopurinol as a cardiovascular drug. Cardiol. Rev. 19, 265–271 (2011 ).

    Not in our library10.1097/crd.0b013e318229a908

20. 20.

    Yang Q.. Multiple genetic loci influence serum urate and their relationship with gout and cardiovascular disease risk factors. Circ. Cardiovasc. Genet. 3, 523–530 (2010 ).

    Not in our library10.1161/circgenetics.109.934455

21. 21.

    Farr B. M., Bartlett C. L., Wadsworth J. & Miller D. L. Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group. Respir. Med. 94, 954–963 (2000 ).

    Not in our library10.1053/rmed.2000.0865

22. 22.

    Ingebrigtsen T. S.. Characteristics of undertreatment in COPD in the general population. Chest 144, 1811–1818 (2013 ).

    Not in our library10.1378/chest.13-0453

23. 23.

    van Dongen S. Graph clustering by flow simulation PhD thesis (Univ. Utrecht (2000 ).

    Not in our library

Cited by papers we hold 7

• A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories · 2023
  No notice
• Twelve-year clinical trajectories of multimorbidity in a population of older adults · 2020
  No notice
• Debutant iOS app and gene-disease complexities in clinical genomics and precision medicine · 2019
  Not checked
• Population-wide analysis of differences in disease progression patterns in men and women · 2019
  No notice
• UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER · 2019
  No notice
• Opportunities and obstacles for deep learning in biology and medicine · 2018
  No notice
• Big data from electronic health records for early and late translational cardiovascular research: challenges and potential · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.